CynosBio, Inc. CynosBio, Inc.

  • ANNOUNCEMENTS
  • PIPELINE
  • ABOUT US
  • CONTACT
    • JP
    • /
    • EN

ANNOUNCEMENTS

  • TOP
  • ANNOUNCEMENTS
  • ALL
  • Announcements for products
  • Company information
  • Newsletters
  • 2025.03.25

    Announcements for products

    Announcement of the start of Phase III clinical trials of IK-01 for the treatment of osteoarthritis of the knee

  • 2023.02.20

    Newsletters

    Announcement on the conclusion of a joint development agreement

  • 2023.02.15

    Newsletters

    Announcement on launch of Sakracy

  • 2022.12.01

    Company information

    Announcement on change of representative director

  • 2022.11.30

    Company information

    Announcement on year-end and new year holidays

  • 2022.08.17

    Newsletters

    Announcement on capital and business alliance with the Cyberdyne group

  • 2022.08.04

    Newsletters

    Announcement on approval of reimbursement listing

  • 2022.02.04

    Newsletters

    Sakracy joint press conference held

  • 2022.01.20

    Newsletters

    Announcement on acquisition of marketing authorization

  • 2021.12.07

    Newsletters

    Announcement on approval by the committee

  • 1
  • 2
A microscope featuring two distinct lenses, positioned on a laboratory table with a neutral background.

CONTACT US

Inquiry for products
Inquiry from outside of Japan is available only the contact by form (E-mail)

CONTACT FORM

About products (Sakracy・IK-01)

+81-120-980-518

Other

+81-3-6457-9861

CynosBio株式会社 CynosBio, Inc.

©2025 CynosBio, Inc.

  • ANNOUNCEMENTS
  • PIPELINE
  • ABOUT US
  • CONTACT
  • PRIVACY POLICY